Evidence map›Paper›PMID 42453301›Full record

ArticleJAC-antimicrobial resistance2026

Impact in production costs resulting from the adoption of interventions to reduce antimicrobials in pig production in Europe: findings from EU-project AVANT.

João S Afonso, Chantal M Morel, Anouschka Middelkoop, Joas Priem, Francesc Molist, Mathieu Gloaguen, Arnaud Buchet, Gunner Sørensen, Sally V Hansen, Jens P Nielsen and 2 more

Abstract read
In one paragraph

Article in JAC-antimicrobial resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

João S AfonsoDepartment of Livestock and One Health, Institute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool, UK.ORCID https://orcid.org/0000-0002-8747-2443
Chantal M MorelKPM Center for Public Management, University of Bern, Schanzeneckstrasse 1, Bern 3012, Switzerland.
Anouschka MiddelkoopSchothorst Feed Research B.V., NA 8218, Lelystad, The Netherlands.
Joas PriemSchothorst Feed Research B.V., NA 8218, Lelystad, The Netherlands.
Francesc MolistSchothorst Feed Research B.V., NA 8218, Lelystad, The Netherlands.
Mathieu GloaguenCooperl Innovation SAS, 1 Rue de la Gare, Plestan 22640, France.
Arnaud BuchetCooperl Innovation SAS, 1 Rue de la Gare, Plestan 22640, France.
Gunner SørensenSEGES Innovation P/S, Copenhagen, Denmark.
Sally V HansenSEGES Innovation P/S, Copenhagen, Denmark.
Jens P NielsenDepartment of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg C 1870, Denmark.
Luca GuardabassiDepartment of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg C 1870, Denmark.ORCID https://orcid.org/0000-0002-2389-5084
Jonathan RushtonDepartment of Livestock and One Health, Institute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Antimicrobial resistance is a major global health threat, with antimicrobial use recognized as a key driver. The post-weaning period is one of the most antimicrobial-intensive phases in pig production. This study assessed the impact on production costs of feed-based and immunomodulatory interventions designed to reduce antimicrobial use in European pig production. Materials and methods: Within the EU-funded AVANT project, we evaluated feed-based strategies (alfalfa diets and high-fibre/low-protein 'secure' feed) and immunomodulatory interventions (faecal filtrate transplantation and vaccination against Shiga-producing Results: Feed-based interventions for piglets accounted for a small share of total feed costs and increased production costs by <0.2% at EU level. Vaccination against Shiga-producing Conclusions: Feed-based strategies and vaccination represent accessible and affordable options to reduce antimicrobial use in pig production in Europe. More innovative approaches such as faecal filtrate transplantation remain costly under experimental conditions but may become economically viable through regulatory approval, market development and economies of scale.

Identifiers

PMID42453301
PMCPMC13366534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.